
Inari Medical, Inc. – NASDAQ:NARI
Inari Medical stock price today
Inari Medical stock price monthly change
Inari Medical stock price quarterly change
Inari Medical stock price yearly change
Inari Medical key metrics
Market Cap | 3.15B |
Enterprise value | 3.50B |
P/E | -111.54 |
EV/Sales | 9.12 |
EV/EBITDA | -186.45 |
Price/Sales | 9.20 |
Price/Book | 8.46 |
PEG ratio | 0.29 |
EPS | -0.40 |
Revenue | 520.65M |
EBITDA | 11.26M |
Income | -23.62M |
Revenue Q/Q | 23.26% |
Revenue Y/Y | 26.10% |
Profit margin | -7.63% |
Oper. margin | -7.33% |
Gross margin | 88.39% |
EBIT margin | -7.33% |
EBITDA margin | 2.16% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeInari Medical stock price history
Inari Medical stock forecast
Inari Medical financial statements
$64
Potential downside: -19.97%
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 119.00M | 2.08M | 1.75% |
---|---|---|---|
Sep 2023 | 126.36M | 3.16M | 2.5% |
Dec 2023 | 132.09M | -4.66M | -3.53% |
Mar 2024 | 143.19M | -24.20M | -16.9% |
2024-02-28 | -0.00375 | 0.05 |
---|
Jun 2023 | 524968000 | 89.32M | 17.01% |
---|---|---|---|
Sep 2023 | 548835000 | 96.69M | 17.62% |
Dec 2023 | 674235000 | 209.32M | 31.05% |
Mar 2024 | 661776000 | 214.54M | 32.42% |
Jun 2023 | 9.76M | -6.08M | -2.35M |
---|---|---|---|
Sep 2023 | 15.93M | 11.82M | 3.46M |
Dec 2023 | 12.24M | -59.71M | -2.41M |
Mar 2024 | -12.28M | 39.16M | 1.01M |
Inari Medical alternative data
Aug 2023 | 1,100 |
---|---|
Sep 2023 | 1,100 |
Oct 2023 | 1,100 |
Nov 2023 | 1,100 |
Dec 2023 | 1,100 |
Jan 2024 | 1,100 |
Feb 2024 | 1,100 |
Mar 2024 | 1,300 |
Apr 2024 | 1,300 |
May 2024 | 1,300 |
Jun 2024 | 1,300 |
Jul 2024 | 1,300 |
Inari Medical other data
Period | Buy | Sel |
---|---|---|
May 2021 | 0 | 114000 |
Jun 2021 | 0 | 73000 |
Jul 2021 | 0 | 242085 |
Aug 2021 | 0 | 56000 |
Sep 2021 | 0 | 56000 |
Oct 2021 | 0 | 156000 |
Nov 2021 | 0 | 47000 |
Dec 2021 | 0 | 109222 |
Jan 2022 | 0 | 42500 |
Feb 2022 | 0 | 66802 |
Mar 2022 | 0 | 90198 |
Apr 2022 | 0 | 40000 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Option | HOFFMAN WILLIAM director, officer.. | Stock Options (Right to buy) | 30,000 | $0.43 | $12,840 | ||
Sale | HOFFMAN WILLIAM director, officer.. | Common Stock | 20,080 | $90.63 | $1,819,850 | ||
Sale | HOFFMAN WILLIAM director, officer.. | Common Stock | 7,149 | $89.77 | $641,766 | ||
Sale | HOFFMAN WILLIAM director, officer.. | Common Stock | 2,771 | $88.78 | $246,009 | ||
Option | HOFFMAN WILLIAM director, officer.. | Common Stock | 30,000 | $0.43 | $12,840 | ||
Sale | HYKES ANDREW officer: Chief Op.. | Common Stock | 1,606 | $92.1 | $147,913 | ||
Sale | HYKES ANDREW officer: Chief Op.. | Common Stock | 3,394 | $91.63 | $310,992 | ||
Sale | HYKES ANDREW officer: Chief Op.. | Common Stock | 1,373 | $91.86 | $126,124 | ||
Sale | HYKES ANDREW officer: Chief Op.. | Common Stock | 1,020 | $90.73 | $92,545 | ||
Sale | HYKES ANDREW officer: Chief Op.. | Common Stock | 2,607 | $89.76 | $234,004 |
Patent |
---|
Application Filling date: 11 Oct 2021 Issue date: 4 Aug 2022 |
Application Filling date: 25 Mar 2022 Issue date: 7 Jul 2022 |
Application Filling date: 25 Mar 2022 Issue date: 7 Jul 2022 |
Application Filling date: 11 Feb 2022 Issue date: 26 May 2022 |
Application Filling date: 11 Feb 2022 Issue date: 26 May 2022 |
Application Filling date: 17 Nov 2021 Issue date: 19 May 2022 |
Application Filling date: 10 Nov 2021 Issue date: 12 May 2022 |
Application Filling date: 6 Aug 2021 Issue date: 10 Feb 2022 |
Application Filling date: 24 Jun 2021 Issue date: 27 Jan 2022 |
Application Filling date: 29 Jun 2021 Issue date: 20 Jan 2022 |
Quarter | Transcript |
---|---|
Q1 2024 30 Apr 2024 | Q1 2024 Earnings Call Transcript |
Q4 2023 28 Feb 2024 | Q4 2023 Earnings Call Transcript |
Q3 2023 1 Nov 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 2 Aug 2023 | Q2 2023 Earnings Call Transcript |
Insider | Compensation |
---|---|
Mr. William H. Hoffman (1967) Chief Executive Officer, Pres & Director | $1,130,000 |
Dr. Thomas M. Tu M.D. (1973) Chief Medical Officer | $904,220 |
Mr. Andrew J. Hykes (1973) Chief Operating Officer | $721,280 |
Inari Medical: Top Buy For End Of 2023 And 2024
Inari Medical: Approaching Interesting Levels
Inari Medical: Targeting Underpenetrated $5.8 Billion Thromboembolism Market
Inari Medical: Reinvesting Heavily Into Growing International Markets
Inari Medical: Retain Buy, No Change To Targets Despite Flat Price Action
Inari Medical: Growth Set To Reaccelerate In The Back Half Of The Year
Sector Rerating Has Cast A Shadow Over Penumbra
Inari Medical: Fundamentals Soft, Technicals Supportive Of Near-Term Upside Capture
Penumbra A Little Beaten Down Despite Strong Growth Opportunities
-
What's the price of Inari Medical stock today?
One share of Inari Medical stock can currently be purchased for approximately $79.98.
-
When is Inari Medical's next earnings date?
Unfortunately, Inari Medical's (NARI) next earnings date is currently unknown.
-
Does Inari Medical pay dividends?
No, Inari Medical does not pay dividends.
-
How much money does Inari Medical make?
Inari Medical has a market capitalization of 3.15B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 28.73% to 493.63M US dollars. Inari Medical made a loss 1.64M US dollars in net income (profit) last year or $0.05 on an earnings per share basis.
-
What is Inari Medical's stock symbol?
Inari Medical, Inc. is traded on the NASDAQ under the ticker symbol "NARI".
-
What is Inari Medical's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of Inari Medical?
Shares of Inari Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Inari Medical's key executives?
Inari Medical's management team includes the following people:
- Mr. William H. Hoffman Chief Executive Officer, Pres & Director(age: 58, pay: $1,130,000)
- Dr. Thomas M. Tu M.D. Chief Medical Officer(age: 52, pay: $904,220)
- Mr. Andrew J. Hykes Chief Operating Officer(age: 52, pay: $721,280)
-
How many employees does Inari Medical have?
As Jul 2024, Inari Medical employs 1,300 workers.
-
When Inari Medical went public?
Inari Medical, Inc. is publicly traded company for more then 5 years since IPO on 22 May 2020.
-
What is Inari Medical's official website?
The official website for Inari Medical is inarimedical.com.
-
Where are Inari Medical's headquarters?
Inari Medical is headquartered at 6001 Oak Canyon, Irvine, CA.
-
How can i contact Inari Medical?
Inari Medical's mailing address is 6001 Oak Canyon, Irvine, CA and company can be reached via phone at 877 923 4747.
-
What is Inari Medical stock forecast & price target?
Based on 8 Wall Street analysts` predicted price targets for Inari Medical in the last 12 months, the avarage price target is $64. The average price target represents a -19.97% change from the last price of $79.98.
Inari Medical company profile:

Inari Medical, Inc.
inarimedical.comNASDAQ
1,300
Medical - Devices
Healthcare
Inari Medical, Inc., a medical device company, develops, manufactures, markets, and sells devices for the interventional treatment of venous diseases in the United States. The company provides ClotTriever, a mechanical thrombectomy system, which is designed to core, capture, and remove large clots from large vessels, as well as for treatment of deep vein thrombosis; and FlowTriever, a large bore catheter-based aspiration and mechanical thrombectomy system, for treatment of pulmonary embolism. It also offers FlowSaver; FlowStasis, a large bore suture retention device designed to address various aspects of venous access site; and FlowTriever 2, a new disk shape designed to capture and remove wall adherent clot and shorten treatment. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.
Irvine, CA 92618
CIK: 0001531048
ISIN: US45332Y1091
CUSIP: 45332Y109